Publications by authors named "R Fresco"

Claim this Profile
R
Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial.
Peter A Fasching, Daniil Stroyakovskiy, Denise A Yardley, Chiun-Sheng Huang, John Crown, Rodrigo Fresco

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial.
Peter A Fasching, Dennis Slamon, Zbigniew Nowecki, Bozena Kukielka-Budny, Daniil Stroyakovskiy, Rodrigo Fresco

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Potential of Macroalgae for Sustainable Crop Production in Agriculture.
Domenico Prisa, Roberto Fresco, Aftab Jamal, Muhammad Farhan Saeed, Damiano Spagnuolo

Life (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribociclib plus Endocrine Therapy in Early Breast Cancer.
Dennis Slamon, Oleg Lipatov, Zbigniew Nowecki, Nicholas McAndrew, Bozena Kukielka-Budny, Rodrigo Fresco

N Engl J Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy endocrine therapy alone in patients with HR+/HER2- early breast cancer.
Dennis J Slamon, Peter A Fasching, Sara Hurvitz, Stephen Chia, John Crown, Rodrigo Fresco

Ther Adv Med Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis